Roundys, FX Allianc...
Health Care: Drugs
Micromet Inc. (MITI: NASDAQ)
$10.97 0.02 | 0.18%
02/09/12 - 04:00 PM ET
1.65M / 583.50K
Vol / Avg. Vol:10.95 / 10.95
Open / Prev. Close:10.95 - 10.97
Today's Range:4.13 - 10.99
52 Wk Range:52.29%
Performance YTD:TheStreet Rating:
Portfolios with MITI
- Portfolio NameUser Type
- Usersam-1
- Userb_rabbit
- ContributorBarron's Activist Stocks 3-...
- UserPART 7 JPMorgan 28th Annual...
- ContributorEarly Volume Plays: Oct. 29
- Userchancepooh Portfolio 1
- UserRAPTOR SPRTD BUY LIST-21100...
- ContributorBarron's Insider Purchases ...
- Uservitaliir Portfolio 1
- Userbiotech picks
Latest MITI Headlines from TheStreet
- JC Penney, Netflix, Micromet Are Big Movers 01.26.12 | 04:01 pm
- Amgen Acquires Micromet for $1.16 Billion 01.26.12 | 08:01 am
- Micromet Stock Hits New 52-Week Low (MITI) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Transcept Pharma 07.08.11 | 06:07 am
- Stocks Under $10: Biotech Bargain Play
06.22.11 | 09:06 am - Micromet Stock Hits New 52-Week Low (MITI) 03.23.11 | 10:03 am
- Micromet Stock Falls On Unusually High Volume (MITI) 03.18.11 | 04:03 pm
- Micromet Stock Hits New 52-Week Low (MITI) 03.15.11 | 10:03 am
- Biotech Stock Mailbag Readers' Portfolio: Update 08.17.10 | 11:08 am
- Micromet, Inc. Q1 2010 Earnings Call Transcript 05.05.10 | 02:05 pm
Press Releases for MITI
- Buyout Offer For Micromet Triggers Shareholder-Claim Investigation By Goldfarb LLP Securities Attorneys - PR Newswire 02.03.12 | 01:02 pm
- Bull & Lifshitz, LLP Announces Investigation Of Micromet, Inc. - PR Newswire 02.02.12 | 11:02 am
- Faruqi & Faruqi, LLP Announces Investigation Of Micromet, Inc. - Business Wire 01.28.12 | 08:01 am
- The Law Firm Of Weiss & Lurie Investigates Micromet, Inc. - Business Wire 01.27.12 | 06:01 pm
- Harwood Feffer LLP Announces Investigation Of Micromet Inc. - Business Wire 01.27.12 | 05:01 pm
- Ryan & Maniskas, LLP Announces Investigation Of Micromet, Inc. - Business Wire 01.26.12 | 07:01 pm
- Finkelstein Thompson LLP Announces Investigation Of Micromet, Inc. - Business Wire 01.26.12 | 06:01 pm
- Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Micromet, Inc. - Business Wire 01.26.12 | 12:01 pm
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Micromet, Inc. In Connection With The Sale Of The Company To Amgen Inc. - Business Wire 01.26.12 | 11:01 am
- Micromet, Inc. Investor Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate The Board Of Micromet Concerning The Sale Of MITI To Amgen - PR Newswire 01.26.12 | 10:01 am
Partner Headlines for MITI
- Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach - Seeking Alpha 01.30.12 | 09:01 am
- Big Biotech Fuels M&A Activity - Seeking Alpha 01.29.12 | 07:01 am
- Momentum Trading: These 6 Stocks Are Up More Than 50% Already in 2012 - Benzinga 01.27.12 | 03:01 pm
- Amgen Misses; 2012 Outlook Strong - Analyst Blog - Zacks 01.27.12 | 10:01 am
- Micromet Loss Widens, Revs Let Down - Analyst Blog - Zacks 11.09.11 | 09:11 am
- Risk-Reward Balanced at Micromet - Analyst Blog - Zacks 09.12.11 | 07:09 pm
- Are These 10 Sick Healthcare Companies Terminally Ill? - Seeking Alpha 07.07.11 | 09:07 am
- Promising Leukemia Drug Boosts Micromet - Benzinga 06.11.11 | 11:06 am
- UPDATE 2-Micromet drug helps 75 pct of leukaemia patients - Reuters 06.10.11 | 11:06 am
- Micromet drug helps 75 pct of leukaemia patients - Reuters 06.10.11 | 04:06 am
